Cataracts may be caused by crystallin interactions in lens

Article

Cataractogenesis may be the result of the interaction of crystallin-derived peptides with intact crystallins in the lens, according to a study published in the March 2008 issue of the Journal of Biological Chemistry.

Cataractogenesis may be the result of the interaction of crystallin-derived peptides with intact crystallins in the lens, according to a study published in the March 2008 issue of the Journal of Biological Chemistry.

Professor K. Krishna Sharma of the University of Missouri, US and colleagues used mass spectroscopy to identify 23 low molecular mass (<3.5 kDa) peptides in the urea-soluble fractions of young, aged, and aged cataract human lenses. The team synthesized two peptides found in the aged and aged cataract lenses, and one peptide found in all three, to study their interactions with intact crystallins and alcohol dehydrogenase.

The researchers discovered that, subsequent to interaction with intact crystallin subunits were less able to function as molecular chaperones, and that the presence of these peptides in place of hydrophobic residues eliminated their ability to induce crystalline aggregation and light scattering.

Thus the researchers concluded that cataracts may be caused by the increased amount of peptides in aged lenses interacting with intact crystallins and reducing chaperoning activity.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.